Kids Channel
Topics
Medications
Quicklinks
Related Channels

Synagis Infants Prophylaxis

Synagis® (palivizumab) is a medication given to high-risk children and infants to help prevent serious infections caused by respiratory syncytial virus (RSV). Synagis is a type of prophylaxis, a measure used to prevent certain medical problems. By giving this medicine to young children, it can help prevent the RSV infection from causing severe complications.
 
Synagis is given as a monthly injection into a muscle (an intramuscular, or IM, injection). The drug cannot prevent a child from getting RSV, but it can help prevent the infection from becoming more serious. This medicine is specifically designed for children age 24 months and younger who have a high risk for developing serious complications from RSV. Some of these high-risk cases include children who:
 
  • Were born prematurely (defined as at or before 35 weeks gestation)
  • Have chronic lung disease
  • Have certain types of congenital heart disease.
 
(For more information on using this prophylaxis in children and infants, click Synagis Uses. This full-length article gives more details on this drug, including how it works to prevent serious complications caused by RSV infections.)
A Dose of Reassurance for Parents of Picky Eaters
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.